Should health-related quality of life be measured in cancer symptom management clinical trials? Lessons learned using the functional assessment of cancer therapy.

MLA

Cella, David, et al. “Should Health-Related Quality of Life Be Measured in Cancer Symptom Management Clinical Trials? Lessons Learned Using the Functional Assessment of Cancer Therapy.” Journal of the National Cancer Institute. Monographs, no. 37, 2007, pp. 53–60. EBSCOhost, https://doi.org/10.1093/jncimonographs/lgm009.

APA

Cella, D., Wagner, L., Cashy, J., Hensing, T. A., Yount, S., & Lilenbaum, R. C. (2007). Should health-related quality of life be measured in cancer symptom management clinical trials? Lessons learned using the functional assessment of cancer therapy. Journal of the National Cancer Institute. Monographs, 37, 53–60. https://doi.org/10.1093/jncimonographs/lgm009

Chicago

Cella, David, Lynne Wagner, John Cashy, Thomas A Hensing, Susan Yount, and Rogerio C Lilenbaum. 2007. “Should Health-Related Quality of Life Be Measured in Cancer Symptom Management Clinical Trials? Lessons Learned Using the Functional Assessment of Cancer Therapy.” Journal of the National Cancer Institute. Monographs, no. 37: 53–60. doi:10.1093/jncimonographs/lgm009.